Navigation Links
Study Redefines Placebo Effect as Part of Effective Treatment
Date:12/22/2009

It's not Drug or Placebo; It's Drug and Placebo

ROCHESTER, N.Y., Dec. 22 /PRNewswire-USNewswire/ -- Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published online today in the journal Psychosomatic Medicine. Early results in human patients suggest that the new technique could improve treatment for several chronic diseases that involve mental state or the immune system, including asthma, multiple sclerosis and chronic pain.

By designing treatment regimens that mix active drug and placebo, researchers at the University of Rochester Medical Center hope to maximize drug benefits, reduce side effects, increase the number of patients who take their medicine and extend the use of drugs otherwise limited by addiction risk or toxicity. Using a fraction of the usual drug dose to get the same effect could also make possible a dramatic and timely reduction in healthcare costs, according to the authors.

The publication is a product of decades of research in the emerging field of "psychoneuro-immunology," which holds that the ability of the human immune system to fight disease is closely linked with a person's mind. Thoughts and moods are captured in neurochemicals that cause the release of hormones which interact with disease-fighting cells.

The current research team chose psoriasis for their first human experiments because it is chronic, gets worse when patients feel stress and involves the immune system. The condition causes pain and disability in four million Americans as inherited traits and irritants cause the immune system to trigger the too fast production of skin cells, resulting in red, scaly patches of dead skin.

"Our study provides evidence that the placebo effect can make possible the treatment of psoriasis with an amount of drug that sh
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants
3. Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity
4. First Patient Treated in Clinical Study of Cohera Medicals TissuGlu(R) Surgical Adhesive
5. Advanced Life Sciences Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
6. Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study
7. Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study
8. Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study
9. GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer
10. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
11. Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  The recent ... health plans and employer groups scrambling to identify ... a major managed care plan, retail pharmacy chain, ... Healthcare,s $13.3 billion purchase of Catamaran, Rite Aid,s ... announcement to purchase Omni-Care for $10 billion are ...
(Date:5/28/2015)... , May 28, 2015 The ... the Commission,s antitrust suit charging Cephalon, Inc. with ... drug Provigil. The settlement ensures that Teva Pharmaceutical ... make a total of $1.2 billion available to ... who overpaid because of Cephalon,s illegal conduct.  ...
(Date:5/28/2015)... May 28, 2015 Lungpacer Medical, Inc., ... phrenic-nerve-pacing system announced today that it will be ... on Thursday, June 4, 2015 in New York ... a.m. Eastern Time.   About Lungpacer ... preclinical stage medical device company pioneering the development ...
Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
(Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey has been ... by Congress to examine how to best deliver health ... commission by Mitch McConnell, majority leader of the U.S. ... voting members on the panel, which was established by ... The goal of the commission is to examine how ...
(Date:5/28/2015)... 2015 The Clinical Data Interchange ... the International Organization for Standardization (ISO) now recognizes ... Model version 3.2 as a published, Final International ... healthcare. This standard, which had previously passed through ... unanimously approved on 24 April for publication by ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will participate ... the strength, passion and endurance of those facing Alzheimer’s ... this sunrise-to-sunset event symbolizes the challenging journey of those ... funds and awareness to advance the care, support and ... encouraged to create their own experience as they fundraise ...
(Date:5/28/2015)... Calif. (PRWEB) May 28, 2015 Restricting ... prevent firearm violence, but policies that more clearly define ... to a review of existing research and public policies ... The analysis, published online April 30 in the peer-reviewed ... drinking and other forms of alcohol misuse in association ...
(Date:5/28/2015)... May 28, 2015 Three years ago, Dr. ... for his Shore Vascular & Vein Center! Dr. ... system. It is his mission to provide the highest ... , Dr. Jeffrey Gosin is Board Certified in ... University of Pennsylvania and Jefferson Medical College. He completed a ...
Breaking Medicine News(10 mins):Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3
... team of German and American researchers have used enetic ... ability to transmit malaria--at least to mice, new study ... the right direction" towards combating malaria in humans, study ... in Ohio. "We now know it is possible to ...
... According to researchers, doctors should begin evaluating people's risk ... levels, beginning at age 20, the American Heart Association ... heart attack and stroke. Thomas Pearson, chairman of the ... years,// and there certainly is an opportunity to make ...
... chocolate every day is connected to good mood and happy ... has long been seen as a pleasurable indulgence.// However, recent ... contains antioxidants, which can protect from chronic disease. ... who eat chocolate regularly are happier than those who do ...
... new study shows some cancer patients who also have ... the drug, interferon.,Past research has suggested a connection between ... //A patient with both of these diseases was treated ... researchers in Paris to study whether the treatment could ...
... women with high levels of lead in their bones face ... lead from sources like old pain, researchers reported recently. In ... of lead exposure// “may constitute a significant public health problem, ... bone.” ,The findings demonstrated that protecting children from the ...
... with medications can reduce abdominal fat in people with type ... looking into the effect that the drug Pioglitazone has on ... the condition, who took the drug for 16 weeks. ... But measurements revealed an interesting redistribution of body fat, inspite ...
Cached Medicine News:Health News: Gene researchers make Malaria-resistant mosquito 2Health News:Heart attack risk starts at 20 2
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... The XCell line of mini-cells has ... sturdy and convenient. The tradition continues ... The incorporation of a gel tension ... wedge used on earlier models makes ...
... is built upon the success of the ... automates all thermal and wash cycles for ... glass slides. A 4-position GeneMachines Hyb4 ... the individual ports allow for independent probe ...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Medicine Products: